CLIMB BIO INCORPORATED (CLYM)

Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

To learn more about CLYM’s potential, visit the Climb Bio, Inc. drug pipeline page. ‘Don’t Get Tempted,’ Says RBC About Palantir Stock Ahead of Monday’s Q2 Earnings

Climb Global Solutions (NASDAQ:CLMB) reported second-quarter results marked by higher gross billings, sales and gross profit, while net income and adjusted EBITDA declined as the company absorbed acquisition-related costs and increased investments in technology infrastructure. For the quarter ended

"Cost went up, prices are going to go up," Qualcomm CEO Cristiano Amon said in an interview.

CLEAN HARBORS ($CLH) posted quarterly earnings results for Q2 2026 on Wednesday, July 29th. The company reported earnings of $3.22 per share, beating estimates of $2.83 by $0.39. The company also reported revenue of $1,735,010,000, beating estimates of $1,655,861,983 by $79,148,017.You can ...